Very early onset schizophrenia and clozapine: Case report;Çok erken başlangiçli şizofreni ve klozapin: Olgu sunumu

Klinik Psikofarmakoloji Bulteni

Volumn 16, Issue 1, 2006, Pages 47-51

  Pekcanlar Akay, Aynur ^a   Doǧan, Özlem ^a   Emiroǧlu, F Neslihan Inal ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Clozapine; Diagnosis; Differential diagnosis; Treatment; Very early onset schizophrenia

Indexed keywords

CLOZAPINE;

ANAMNESIS; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; ONSET AGE; SCHIZOPHRENIA; SCHOOL CHILD;

EID: 33645554539     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Werry JS, McClellan JM. Predicting outcome in child and adolescent schizophrenia and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1992;31:147-150
2. Gillberg C, Wahlstrom J, Forsman A, Hellgren L, Gillberg IC. Teenage psychosis: epidemiology, clssification and reduced optimality in the pre-, peri- and neonatal periods. J Child Psychol Psychiatry 1986;27:87-98
3. Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984;41:157-161
4. Potter HW. Schizophrenia in children. Am J Psychiatry 1993;89:1253-1270
5. Beitchman JH. Childhood schizophrenia: a review and comparison with adult-onset schizophrenia. Psychiatr Clin North Am 1985;8:793-814
6. Niendam M, Bearden C, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry 2003;160:2060-2062
7. Nicholson R, Brookner F, Lenane M, Gochman P, Ingraham LJ, Egan MF, Kendler KS, Pickar D, Weinberger DR, Rapoport JL. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry 2003;160:490-495
8. Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia. Am J Psychiatry 2000;157:1652-1659
9. Peterson BS. Neuroimaging in child and adolescent neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry 1995;34:1560-1576
10. Schmidt M, Blanz B, Dippe A, Koppe T, Lay B. Course of patients diagnosed as having chizophrenia during first episode occurring under age 18 years. Eur Arch Psychiatry Clin Neurosci. 1995;245:93-100
11. Spencer EK, Kafantaris V, Pardon-Gayol M, Rosenberg CR, Campbell M. Haloperidol in schizophrenic children: Early findings from a study in progress. Psychopharmacol Bull 1992;28:183-186
12. Green WH. Child and Adolescent Clinical Psychopharmacology. 2nd ed. Baltimore, Maryland : Williams and Wilkins, 1995:111-113
13. Lieberman JA. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. J Clin Psychiatry 1996;57 (Suppl 11):68-71
14. Toren P, Laor N, Weizman A. Use of atypical neuroleptics in child and adolescent psychiatry. J Clin Psychiatry 1998;59:644-656
15. Malone RP, Sheikh R, Zito JM. Novel antipsychotic medications in the treatment of children and adolescents. Psychiatr Serv 1999;50:171-174
16. Kumra S, Frazier JA, Jakobsen LK, McKenna K, Gordon CT, Lenane CM, Hamburger SD, Smith KA, Albus EK, Rad-Alagliband J, Rapoport LJ. Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996;53:1090-1097
17. Chalasani L, Kant R, Chengappa KN. Clozapine impact on clinical outcomes and agression in severely ill adolaescents with childhood-onset schizophrenia. Can J Psychiatry 2001;46:965-968
18. Kranzler H, Roofeh BA, Gerbino-Rosen G, Dombrowski C, McMeniman M, DeThomas C, Frederickson A, Nusser L, Bienstock MD, Fisch GS, Kurma S. Clozapine: Its impact on agressive behavior among children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 2005;44:55-63
19. McClellan JM, Werry JS. . Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;5:616-663
20. Lay B, Blanz B, Hartman M, Schmidt MH. The psychosocial outcome of adolescent onset schizophrenia: a 12- year followup. Schizophr Bull 2000; 26:801-816
21. Dulcan MK, Bregman J, Weller E. Treatment of childhood and adolescent disorders. In Textbook of Psychopharmacology, Schatzberg AF, Nemeroff CB (editors). 2nd ed., Washington, DC: American Psychiatric Press 1998;806-814
22. Findling RL, Grcevich SJ, Lopez I, Schulz SC. Antipsychotic medications in children and adolescents. J Clin Psychiatry 1996;57 (Suppl. 9):19-23
23. Lieberman JA. Atypical antipsychotic drugs as a first-line treatment of schizophrenia: a rationale and hypothesis. J Clin Psychiatry 1996;57 (Suppl. 11):68-71.
24. Remschmidt H, Schulz E, Martin PDM. An open trial of clozapine in thirty-six adolescents with schizophrenia. J Child Adolesc Psychopharmacol 1994;4:31-41
25. Frazier JA, Gordon CT, McKenna K, Giedd J, Zametkin A, Zahn T, Hommer D, Hong W, Kayser D, Albus KE. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:658-663
26. Meltzer HY. Treatment of the neuroleptic nonresponsive schizophrenic patient. Schizophr Bull 1992;18:515-542
27. Volavka J. The effects of clozapine on agression and substance abuse in schizophrenic patients. J Clin Psychiatry 1999;60 (Suppl 12):43-46